age-related macular degeneration (AMD)

Investigational wet AMD therapies aim for innovative targetsMany investigational drugs under development for the treatment of neovascular age-related macular degeneration (nvAMD) have advanced into the clinical trial stage, including several that are being evaluated in pivotal trials, said Peter K. Kaiser, MD.
Failed cell therapy study offers positives, raises new questionsPatients with a history of frequent anti-vascular endothelial growth factor (anti-VEGF) injections for the treatment of age-related macular degeneration (AMD) may not be the best potential candidates for encapsulated cell technology (ECT).
New research, interest advancing retinal careTreatment of posterior segment disease is in the midst of a paradigm shift, says a panel of experts at this year's annual SECO 2017 conference in Atlanta.
OD education must keep up with industry changesAt this moment, optometric leaders are seemingly wedged between fighting against online refractions and spectacles and fighting for “follow the money/ophthalmologic care.”
Treat-and-extend may lead to better AMD resultsTreating neovascular age-related macular degeneration (nAMD) patients with anti-vascular endothelial growth factor (anti-VEGF) ranibizumab (Lucentis, Genentech) on a monthly regimen has produced “great results” in clinical trials, said Prof. Mark C. Gillies, MBBS, PhD. “But what happens after that and what happens in real world practice?”
Researchers reject vitamin D role in macular degeneration
Researchers reject vitamin D role in macular degenerationAnalyzing data from the European Eye Study, Gareth J. McKay, PhD, of Queen’s University in Belfast, United Kingdom, and colleagues in 7 countries in Europe found no meaningful association between serum 25-hydroxy vitamin D (25(OH)D) and AMD. They published the finding in Ophthalmology.
Mediterranean diet may protect against macular degeneration
Mediterranean diet may protect against macular degenerationThe Mediterranean diet reduces the risk of age-related macular degeneration (AMD), according to a study of two Portuguese populations.
Visual cycle metabolites: Cause of AMD?
Visual cycle metabolites: Cause of AMD?Oxidative stress stemming from a growing accumulation of visual cycle adducts may play an important role in the pathogenesis of AMD, suggest new findings.
Ceeable aims to be the next gold standard in visual fields
Ceeable aims to be the next gold standard in visual fieldsCeeable, a web-based, mobile digital technology designed to detect early-stage eye diseases—an innovation that can help shape 21st century medicine—was awarded third place in the American Medical Association’s inaugural Healthier Nation Innovation Challenge.
Google DeepMind searches for signs of retinopathyGoogle is using its DeepMind computing system to search for early signs of diabetic retinopathy and neovascular age-related macular degeneration (nAMD), the company announced this month.